Masimo MASI recently reported findings from the NeoPODS study, a large prospective real-world evaluation of its SET pulse oximetry technology in critically ill newborns. The study demonstrated less ...

These promising results—from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile patient population—add to previously published evidence of its strong ...

Masimo Corp. today reported study data showing that its pulse oximetry technology accurately monitored hospitalized newborns of all skin tones without dangerous drops in blood oxygen. The findings ...

E1’s premise is simple: identical high-speed electric boats racing in tightly packed, spectator-friendly venues around the world. This year, Sierra Racing Club—majority-owned by Eren and Fatih Ozmen ...

This ultraviolet printer prints on literally anything—canvas, wood, metal, plastic, you name it. Like all things that are the first of their kind, it also costs a heavy premium. Reading time 10 ...

UV printing is a really compelling concept, with a lot of potential versatility for creators to manufacture all sorts of unique artworks. The Eufymake E1 is the first UV printer to bring UV printing ...

Bridger Management sold 47,841 shares of Masimo in the fourth quarter. The move resulted in the quarter-end position value decreasing by $7.06 million. The position was previously 3.8% of fund AUM as ...

A U.S. trade tribunal preliminarily ruled that Apple's AAPL.O current Apple Watches do not infringe patents owned by Masimo MASI.O, rejecting the medical-monitoring company's bid for a renewed import ...

What just happened? Apple's latest Apple Watch redesign has cleared a key hurdle at a US trade agency, easing one immediate threat to its wearable roadmap while leaving a broader, high-stakes patent ...

Apple's current blood oxygen sensing implementation in the U.S. does not infringe on patents owned by Masimo and Apple will not face a revived import ban, a U.S. International Trade Commission judge ...

A US appeals court has found in favor of Masimo in its fight against Apple over pulse oximetry patents, but in the court that matters, a ruling makes it clear that there won't be another ban on the ...